About: Intensification of treatment and survival in all children with lymphoblastic leukaemia: results of UK Medical Research Council trial UKALL X. Medical Research Council Working Party on Childhood Leukaemia

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Intensification of treatment and survival in all children with lymphoblastic leukaemia: results of UK Medical Research Council trial UKALL X. Medical Research Council Working Party on Childhood Leukaemia Goto Sponge Distinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 January 1995

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в січні 1995 (uk) article scientifique publié en 1995 (fr) im Januar 1995 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu en xineru de 1995 (ast) artikull shkencor i botuar më 01 janar 1995 (sq) scientific article published on 01 January 1995 (en)
publication date	wds:Q72414737-D30CA13F-4E4E-4E05-B5A2-7845F291308A
publication date	1995-01-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q72414737-ADCDED4B-779A-4D81-A253-481BDC8E5D51
language of work or name	English
cites work	wds:Q72414737-01835270-85DF-4A7C-B839-6B7A643C1EA6 wds:Q72414737-03CED1BB-765B-4D9E-AA7A-E598BD821C0D wds:Q72414737-149B76D6-C5B5-42ED-AD12-AABACF760883 wds:Q72414737-15F67116-7A1E-4518-ABD2-B17473CEA069 wds:Q72414737-1859FA5E-5BB3-4ADD-8CB1-6E3D66136E92 wds:Q72414737-1EBBC38A-66D1-489C-9165-EDE3A3EA0622 wds:Q72414737-2CB2C5DD-4AD5-450D-BB7E-966CABF041E3 wds:Q72414737-52A79487-8245-472F-9215-3BD115ACB712 wds:Q72414737-582327B5-787A-419F-A874-F672D3A47A13 wds:Q72414737-714E35A1-88AF-4996-B400-1A63F281B359 wds:Q72414737-72EF8CB3-1C09-4DFC-B757-E9E3F61E6E0E wds:Q72414737-7805938C-0E0D-40C3-A9AB-9C2BD4BDE38D wds:Q72414737-854F9389-9636-4FCB-B5B0-5F3709020F6E wds:Q72414737-907ABFB3-DDE1-4C73-AE0B-588289348070 wds:Q72414737-A18A8BC6-FDC3-4C1C-8036-3478237A3954 wds:Q72414737-AB09A657-BDC5-465A-8212-AFE26F4A8D5E wds:Q72414737-AE6297C3-612C-479E-A07D-91F663B776DA wds:Q72414737-B7DC970E-8FF8-4B6E-AB01-1702CD94FB0D wds:Q72414737-C28B5DE3-2F26-4E45-A3F9-1C1A1835E067 wds:Q72414737-C8DDFB95-580D-4692-969A-0D25C5848AA6 wds:Q72414737-CA539742-8A2A-40D7-94CE-8CF1F30A5F99 wds:Q72414737-CF08E0FB-1546-4F35-94B0-34A7F3A053B0 wds:Q72414737-E1FF90E0-B7E1-4D61-AB0A-CFAEA020CED2 wds:Q72414737-FC9F2039-1C28-4CB1-9820-CA82C862B892
cites work	Secondary acute myeloid leukemia in children treated for acute lymphoid leukemia Treatment of acute lymphoblastic leukemia. 30 years' experience at St. Jude Children's Research Hospital Gender and treatment outcome in childhood lymphoblastic leukaemia: report from the MRC UKALL trials Improved outcome with delayed intensification for children with acute lymphoblastic leukemia and intermediate presenting features: a Childrens Cancer Group phase III trial. Late cardiac effects of doxorubicin therapy for acute lymphoblastic leukemia in childhood Four-agent induction and intensive asparaginase therapy for treatment of childhood acute lymphoblastic leukemia. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples Comparative results of two intensive treatment programs for childhood acute lymphoblastic leukemia: The Berlin-Frankfurt-Münster and Dana-Farber Cancer Institute protocols Results of Medical Research Council Childhood Leukaemia Trial UKALL VIII (report to the Medical Research Council on behalf of the Working Party on Leukaemia in Childhood) Allocation of patients to treatment groups in a controlled clinical study Prognostic factors and therapy in acute lymphoblastic leukemia of childhood: CCG-141: A report from childrens cancer study group Intensive consolidation chemotherapy for acute lymphoblastic leukaemia (UKALL X pilot study). Importance of 6-mercaptopurine dose in lymphoblastic leukaemia Reduction in central nervous system leukemia with a pharmacokinetically derived intrathecal methotrexate dosage regimen Improved therapy for children with acute lymphoblastic leukemia and unfavorable presenting features: a follow-up report of the Childrens Cancer Group Study CCG-106 Intermediate-dose intravenous methotrexate and mercaptopurine therapy for non-T, non-B acute lymphocytic leukemia of childhood: a Pediatric Oncology Group study Improved outcome in childhood acute lymphoblastic leukaemia with reinforced early treatment and rotational combination chemotherapy Early response to induction therapy as a predictor of disease-free survival and late recurrence of childhood acute lymphoblastic leukemia: a report from the Childrens Cancer Study Group Testicular irradiation in childhood lymphoblastic leukaemia. Medical Research Council Working Party on Leukemia in Childhoods Impact of chromosomal translocations on prognosis in childhood acute lymphoblastic leukemia Advances in therapy for childhood non-B-lymphoblastic leukaemia Charles F. Kettering Prize. The contribution of statistical methods to cancer research A pilot study of intermediate-dose methotrexate and cytosine arabinoside, "spread-out" or "up-front," in continuation therapy for childhood non-T, non-B acute lymphoblastic leukemia. A Pediatric Oncology Group study Bone marrow transplantation for high-risk childhood lymphoblastic leukaemia in first remission: experience in MRC UKALL X
author name string	wds:Q72414737-05C3AEFC-965D-4BFC-8FFD-CC12FFE00D0D wds:Q72414737-B71DB5CC-F14D-4457-9960-2FE871BB2AFE wds:Q72414737-DD41578F-6209-4402-93CB-89C3B3296FFF
author name string	C Bailey S M Richards J M Chessells
rdfs:label	Intensification of treatment and survival in all children with lymphoblastic leukaemia: results of UK Medical Research Council trial UKALL X. Medical Research Council Working Party on Childhood Leukaemia (en) Intensification of treatment and survival in all children with lymphoblastic leukaemia: results of UK Medical Research Council trial UKALL X. Medical Research Council Working Party on Childhood Leukaemia (nl) Intensification of treatment and survival in all children with lymphoblastic leukaemia: results of UK Medical Research Council trial UKALL X. Medical Research Council Working Party on Childhood Leukaemia (sq)
skos:prefLabel	Intensification of treatment and survival in all children with lymphoblastic leukaemia: results of UK Medical Research Council trial UKALL X. Medical Research Council Working Party on Childhood Leukaemia (en) Intensification of treatment and survival in all children with lymphoblastic leukaemia: results of UK Medical Research Council trial UKALL X. Medical Research Council Working Party on Childhood Leukaemia (nl) Intensification of treatment and survival in all children with lymphoblastic leukaemia: results of UK Medical Research Council trial UKALL X. Medical Research Council Working Party on Childhood Leukaemia (sq)
name	Intensification of treatment and survival in all children with lymphoblastic leukaemia: results of UK Medical Research Council trial UKALL X. Medical Research Council Working Party on Childhood Leukaemia (en) Intensification of treatment and survival in all children with lymphoblastic leukaemia: results of UK Medical Research Council trial UKALL X. Medical Research Council Working Party on Childhood Leukaemia (nl) Intensification of treatment and survival in all children with lymphoblastic leukaemia: results of UK Medical Research Council trial UKALL X. Medical Research Council Working Party on Childhood Leukaemia (sq)
title	wds:Q72414737-4EC5E4B6-F7D5-4F63-B73D-9D76188607B0
title	Intensification of treatment and survival in all children with lymphoblastic leukaemia: results of UK Medical Research Council trial UKALL X. Medical Research Council Working Party on Childhood Leukaemia (en)
page(s)	wds:Q72414737-11C7FB3C-7366-4983-9E46-A1905376B19F
page(s)	143-148
instance of	wds:Q72414737-FE8DC028-3CD6-42A7-AE88-7DC06FCBEC41
instance of	scholarly article
PubMed ID	wds:Q72414737-2774E766-9158-495F-82B3-3D3D1EFDE122
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/7823668
PubMed ID	7823668
published in	wds:Q72414737-A24644EF-D04D-4512-99DF-253FA54D9085
published in	The Lancet
issue	wds:Q72414737-C89208C9-064A-469F-B27B-6EBB0E8BE6E1
volume	wds:Q72414737-15CF6F28-5819-48F5-AB1A-70E5C6E78D65
issue	8943
volume	345
DOI	wds:Q72414737-079ABB75-7E4C-4D2F-92BF-5802281949A5
DOI	http://dx.doi.org/10.1016/S0140-6736(95)90164-7
DOI	10.1016/S0140-6736(95)90164-7
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q72414737
is cites work of	Individual patient data meta-analysis in cancer Patterns of care and survival for children with acute lymphoblastic leukaemia diagnosed between 1980 and 1994. Temporal changes in the incidence and pattern of central nervous system relapses in children with acute lymphoblastic leukaemia treated on four consecutive Medical Research Council trials, 1985-2001. NOTCH1-induced T-cell leukemia in transgenic zebrafish. The treatment of acute leukaemia Gene expression signatures define novel oncogenic pathways in T cell acute lymphoblastic leukemia

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 180 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software